Treating acne with oral contraceptives: Use of lower doses

Contraception

Volumn 73, Issue 1, 2006, Pages 23-29

  Huber, Johannes ^a   Walch, Katharina ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acne; Ethinyl estradiol; Levonorgestrel; Low dose; Oral contraceptives

Indexed keywords

CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; CYPROTERONE ACETATE; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; DIENOGEST PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ETHINYLESTRADIOL PLUS NORGESTREL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; TRI MERCI; TRI MINULET;

ACNE; BLOATING; BREAST TENDERNESS; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LOW DRUG DOSE; NAUSEA; PATIENT COMPLIANCE; QUALITY OF LIFE; REVIEW; SKIN CARE; SKIN DISEASE; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

ACNE VULGARIS; CONTRACEPTIVES, ORAL; CONTROLLED CLINICAL TRIALS; ETHINYL ESTRADIOL; NORETHINDRONE; NORGESTREL; PLACEBOS; PROGESTINS; RANDOMIZED CONTROLLED TRIALS;

EID: 29144433548     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.07.010     Document Type: Review

References (37)

1. D. Thiboutot New treatments and therapeutic strategies for acne Arch Fam Med 9 2000 179 187
2. A. Lemay, S.D. Dewailly, R. Grenier, and J. Huard Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel J Clin Endocrinol Metab 71 1990 8 14
3. I.H. Thorneycroft, F.Z. Stanczyk, K.D. Bradshaw, S.A. Ballagh, M. Nichols, and M.E. Weber Effect of low-dose oral contraceptives on androgenic markers and acne Contraception 60 1999 255 262
4. J. Leyden, A. Shalita, M. Hordinsky, L. Swinyer, F.Z. Stanczyk, and M.E. Weber Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial J Am Acad Dermatol 47 2002 399 409
5. I. Worret, W. Arp, H.P. Zahradnik, J.O. Andreas, and N. Binder Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon) Dermatology 203 2001 38 44
6. D. Thiboutot, D.F. Archer, A. Lemay, K. Washenik, J. Roberts, and D.D. Harrison A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment Fertil Steril 76 2001 461 468
7. G.V. Upton Clinical experience with the triphasic oral contraceptive M. Elstein Update on triphasic oral contraception. Proceedings from a symposium preceding the 10th World Congress on Obstetrics and Gynecology, San Francisco, 17 October 1982 1983 Excerpta Medica Amsterdam 54 74
8. P. Bilotta, and S. Favilla Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive Drug Res 38 1988 932 935
9. F.D. Anderson Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives Acta Obstet Gynecol Scand 71 Suppl. 156 1992 15 21
10. N. Loudon, and S.F. Biddell The effect of the triphasic oral contraceptive on acne vulgaris: an interim report of an open multicenter study M. Elstein Update on triphasic oral contraception. Proceedings from a symposium preceding the 10th World Congress on Obstetrics and Gynecology, San Francisco, 17 October 1982 1983 Excerpta Medica Amsterdam 75 81
11. M.L. Vree, and J. Schmidt A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany Eur J Contracept Reprod Health Care 6 2001 108 114
12. V.N. Prilepskaya, V.N. Serov, and E.V. Zharov Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne Contraception 68 2003 239 245
13. L. Falsetti Acne treatment with a new estroprogestinic biphasic combination containing desogestrel Acta Eur Fertil 22 1991 283 286
14. P.-G. Sator, J.P. Schmidt, and H. Hönigsmann Clinical evidence of the endocrinological influence of a triphasic oral contraceptive containing norgestimate and ethinyl estradiol in treating women with acne vulgaris Dermatology 206 2003 241 248
15. C. Piérard-Franchimont, U. Gaspard, P. Lacante, M. Rhoa, P. Slachmuylders, and G.E. Piérard A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene Eur J Contracept Reprod Health Care 5 2000 275 286
16. T. Zimmerman, K.-H. Wisser, and H. Dietrich The effects of Valette on skin and hair: a post-marketing surveillance study Int J Clin Pract 54 2000 85 91
17. J.A. Miller, F.T. Wojnarowska, and P.M. Dowd Anti-androgen treatment in women with acne: a controlled trial Br J Dermatol 114 1986 705 716
18. L. Carlborg Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study Acta Obstet Gynecol Scand Suppl 134 1986 29 32
19. J.M. Wishart An open study of Triphasil and Diane 50 in the treatment of acne Aust J Dermatol 32 1991 51 54
20. R. Erkkola, E. Hirvonen, J. Luikku, R. Lumme, H. Mannikko, and S. Aydinlik Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms Acta Obstet Gynecol Scand 69 1990 61 65
21. C. Charoenvisal, Y. Thaipisuttikul, and S. Pinjaroen Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate Int J Fertil Menopausal Stud 41 1996 423 429
22. M. Vartiainen, H. de Gezelle, and C.J. Broekmeulen Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate Eur J Contracept Reprod Health Care 6 2001 46 53
23. M. Levrier, H. Degrelle, Y. Bestaux, M. Bourry-Moreno, J.P. Brun, and F. Sailly Efficacité sur l'acné des contraceptifs oraux Rev Fr Gynécol Obstét 83 1988 573 576
24. W.A. van Vloten, C.W. van Haselen, E.J. van Zuuren, C. Gerlinger, and R. Heithecker The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea Cutis 69 2002 2 15
25. D. Mango, S. Ricci, P. Manna, G.A. Miggiano, and G.B. Serra Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris Contraception 53 1996 163 170
26. R. Palatsi, E. Hirvensalo, and P. Liukko Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives Acta Derm Venereol 64 1984 517 523
27. M.P. Rosen, D.M. Breitkopf, and M. Nagamani A randomized controlled trial of second- and third-generation oral contraceptives in the treatment of acne vulgaris Am J Obstet Gynecol 188 2003 1158 1160
28. U.H. Winkler, H. Ferguson, and J.A.P.A. Mulders Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol Contraception 69 2004 469 476
29. I.H. Thorneycroft, H. Gollnick, and I. Schellschmidt Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment Cutis 74 2004 123 130
30. G. Redmond, A.J. Godwin, W. Olson, and J.S. Lippman Use of placebo controls in an oral contraceptive trial: methodological issues and adverse event incidence Contraception 60 1999 81 85
31. G.P. Redmond, W.H. Olson, J.S. Lippman, M.E. Kafrissen, T.M. Jones, and J.L. Jorizzo Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial Obstet Gynecol 89 1997 615 622
32. A.W. Lucky, T.A. Henderson, W.H. Olson, D.M. Robisch, M. Lebwohl, and L.J. Swinyer Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris J Am Acad Dermatol 37 1997 746 754
33. M. Maloney, D.I. Arbit, M. Flack, C. McLaughlin-Miley, C. Sevilla, and R. Derman Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris Clin J Women's Health 2 2001 123 131
34. World Health Organization Steroid contraception and the risk of neoplasia. Report of a WHO Scientific Group World Health Organ Tech Rep Ser 1978 619
35. R.A. Hatcher, and J. Guillebaud The Pill: combined oral contraceptives R.A. Hatcher J. Trussell F. Stewart Contraceptive technology 17th ed. 1998 Ardent Media, Inc New York 405 466
36. M.D. Creinin, B. Clark, and B. Connell Understanding low dose oral contraceptives Clinical Proceedings. A publication of the Association of Reproductive Health Professionals, electronic edition 2001
37. M.J. Rosenberg, A. Meyers, and V. Roy Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations Contraception 60 2000 321 329